BlackRock’s Seelos Therapeutics, Inc. Common Stock SEEL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
|
|||||
|
2024
Q3 | $1.33K | Sell |
|
|||||
|
2024
Q2 | $4.16K | Sell |
|
|||||
|
2024
Q1 | $33.1K | Hold |
|
|||||
|
2023
Q4 | $77.8K | Sell |
|
|||||
|
2023
Q3 | $312K | Buy |
|
|||||
|
2023
Q2 | $2.01M | Buy |
|
|||||
|
2023
Q1 | $1.15M | Sell |
|
|||||
|
2022
Q4 | $1.21M | Buy |
|
|||||
|
2022
Q3 | $1.83M | Hold |
|
|||||
|
2022
Q2 | $1.21M | Sell |
|
|||||
|
2022
Q1 | $5.27M | Sell |
|
|||||
|
2021
Q4 | $10.7M | Buy |
|
|||||
|
2021
Q3 | $15.4M | Buy |
|
|||||
|
2021
Q2 | $14.1M | Buy |
|
|||||
|
2021
Q1 | $5.95M | Buy |
|
|||||
|
2020
Q4 | $876K | Hold |
|
|||||
|
2020
Q3 | $520K | Hold |
|
|||||
|
2020
Q2 | $560K | Buy |
|
|||||
|
2020
Q1 | $210K | Buy |
|
|||||
|
2019
Q4 | $541K | Buy |
|
|||||
|
2019
Q3 | $288K | Buy |
|
|||||
|
2019
Q2 | $682K | Buy |
|
|||||
|
2019
Q1 | $908K | Buy |
|
|||||
|
2018
Q4 | $16K | Hold |
|
|||||
|
2018
Q3 | $27K | Hold |
|
|||||
|
2018
Q2 | $33K | Hold |
|
|||||
|
2018
Q1 | $36K | Hold |
|
|||||
|
2017
Q4 | $161K | Hold |
|
|||||
|
2017
Q3 | $150K | Buy |
|
|||||
|
2017
Q2 | – | Hold |
|
|||||
|
2017
Q1 | – | Hold |
|
|||||
|
2016
Q4 | – | Hold |
|
|||||
|
2016
Q3 | – | Hold |
|
|||||
|
2016
Q2 | – | Hold |
|
|||||
|
2016
Q1 | – | Hold |
|
|||||
|
2015
Q4 | – | Hold |
|